AptarGroup, Inc. (NYSE:ATR) Plans Dividend Increase – $0.45 Per Share

AptarGroup, Inc. (NYSE:ATR) declared a quarterly dividend on Thursday, July 11th, RTT News reports. Investors of record on Thursday, July 25th will be paid a dividend of 0.45 per share by the industrial products company on Thursday, August 15th. This represents a $1.80 annualized dividend and a dividend yield of 1.23%. The ex-dividend date is Thursday, July 25th. This is an increase from AptarGroup’s previous quarterly dividend of $0.41.

AptarGroup has increased its dividend payment by an average of 3.1% per year over the last three years and has raised its dividend annually for the last 31 consecutive years. AptarGroup has a dividend payout ratio of 30.8% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect AptarGroup to earn $5.89 per share next year, which means the company should continue to be able to cover its $1.80 annual dividend with an expected future payout ratio of 30.6%.

AptarGroup Stock Performance

Shares of ATR opened at $145.98 on Wednesday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.89 and a current ratio of 1.30. The company has a market capitalization of $9.67 billion, a price-to-earnings ratio of 31.33, a PEG ratio of 3.25 and a beta of 0.57. The company’s 50 day simple moving average is $145.25 and its 200 day simple moving average is $140.92. AptarGroup has a 1 year low of $118.71 and a 1 year high of $151.73.

AptarGroup (NYSE:ATR) last announced its quarterly earnings data on Thursday, April 25th. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.13 by $0.13. AptarGroup had a net margin of 8.83% and a return on equity of 15.06%. The business had revenue of $915.45 million for the quarter, compared to the consensus estimate of $897.40 million. On average, sell-side analysts predict that AptarGroup will post 5.35 EPS for the current year.

Analyst Upgrades and Downgrades

ATR has been the subject of several research analyst reports. William Blair raised shares of AptarGroup from a “market perform” rating to an “outperform” rating in a research report on Monday, April 29th. Robert W. Baird upped their price target on shares of AptarGroup from $150.00 to $170.00 and gave the stock an “outperform” rating in a research report on Monday, April 29th. Finally, Wells Fargo & Company upped their price target on shares of AptarGroup from $163.00 to $168.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th.

Insider Activity

In other news, insider Hedi Tlili sold 4,634 shares of the firm’s stock in a transaction on Wednesday, May 1st. The shares were sold at an average price of $145.09, for a total value of $672,347.06. Following the transaction, the insider now owns 9,379 shares of the company’s stock, valued at approximately $1,360,799.11. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, insider Hedi Tlili sold 4,634 shares of the firm’s stock in a transaction on Wednesday, May 1st. The shares were sold at an average price of $145.09, for a total value of $672,347.06. Following the transaction, the insider now owns 9,379 shares of the company’s stock, valued at approximately $1,360,799.11. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Kimberly Chainey sold 825 shares of the firm’s stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $146.77, for a total transaction of $121,085.25. Following the completion of the transaction, the executive vice president now directly owns 8,812 shares in the company, valued at approximately $1,293,337.24. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 8,659 shares of company stock valued at $1,269,976. Company insiders own 1.00% of the company’s stock.

About AptarGroup

AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.